Hydrophobic dopamine agonists administered to the dermis
CA 2452393 A1 · Owner: Pharmacia Corporation · Inventors: Pinkerton, Thomas C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for systemic administration of a hydrophobic dopamine agonist to a mammal is disclosed. The method involves delivering t he hydrophobic dopamine agonist to the dermis of the mammal whereby improved systemic absorption is obtained compared to absorption produced upon delivering the substance subcutaneously by bolus administration.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.